Clinically relevant molecular subtypes in leiomyosarcoma

PURPOSE: Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Guo, Xiangqian, Jo, Vickie Young, Mills, Anne M., Zhu, Shirley X., Lee, Cheng-Han, Espinosa, Inigo, Nucci, Marisa Rose, Varma, Sushama, Forgó, Erna, Hastie, Trevor, Anderson, Sharon, Ganjoo, Kristen, Beck, Andrew H., West, Robert B., Fletcher, Christopher, van de Rijn, Matt
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526352/
https://ncbi.nlm.nih.gov/pubmed/25896974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars